Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Amin

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
American Journal of Respiratory Cell and Molecular Biology|July 1, 1995
Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancerH C Hwang, W R Smythe, A A Elshami, et al.
Cancer Research|August 17, 2001
Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunityM Odaka, D H Sterman, R Wiewrodt, et al.
The American Journal of Pathology|February 1, 1995
Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesotheliomaK M Amin, L A Litzky, W R Smythe, et al.
Cancer Research|June 13, 2000
Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor modelsM Lanuti, S Rudginsky, S D Force, et al.
Human Gene Therapy|February 27, 1999
Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapyM Lanuti, G P Gao, S D Force, et al.
Human Gene Therapy|June 2, 1998
Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesotheliomaD H Sterman, J Treat, L A Litzky, et al.
Human Gene Therapy|December 1, 1996
Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primatesJ C Kucharczuk, S Raper, A A Elshami, et al.
The Annals of Thoracic Surgery|September 1, 1995
Pleural-based mesothelioma in immune competent rats: a model to study adenoviral gene transferJ C Kucharczuk, A A Elshami, H B Zhang, et al.
Cancer Gene Therapy|July 1, 1997
The effect of promoter strength in adenoviral vectors containing herpes simplex virus thymidine kinase on cancer gene therapy in vitro and in vivoA A Elshami, J W Cook, K M Amin, et al.
Cancer Gene Therapy|March 3, 2001
A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesotheliomaD H Sterman, K Molnar-Kimber, T Iyengar, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
American Journal of Respiratory Cell and Molecular Biology|July 1, 1995
Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancerH C Hwang, W R Smythe, A A Elshami, et al.
Cancer Research|August 17, 2001
Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunityM Odaka, D H Sterman, R Wiewrodt, et al.
The American Journal of Pathology|February 1, 1995
Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesotheliomaK M Amin, L A Litzky, W R Smythe, et al.
Cancer Research|June 13, 2000
Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor modelsM Lanuti, S Rudginsky, S D Force, et al.
Human Gene Therapy|February 27, 1999
Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapyM Lanuti, G P Gao, S D Force, et al.
Human Gene Therapy|June 2, 1998
Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesotheliomaD H Sterman, J Treat, L A Litzky, et al.
Human Gene Therapy|December 1, 1996
Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primatesJ C Kucharczuk, S Raper, A A Elshami, et al.
The Annals of Thoracic Surgery|September 1, 1995
Pleural-based mesothelioma in immune competent rats: a model to study adenoviral gene transferJ C Kucharczuk, A A Elshami, H B Zhang, et al.
Cancer Gene Therapy|July 1, 1997
The effect of promoter strength in adenoviral vectors containing herpes simplex virus thymidine kinase on cancer gene therapy in vitro and in vivoA A Elshami, J W Cook, K M Amin, et al.
Cancer Gene Therapy|March 3, 2001
A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesotheliomaD H Sterman, K Molnar-Kimber, T Iyengar, et al.
Pageof 4